← FDA Drug Approvals (Drugs@FDA)

EMBOLEX

NDA · New Drug Application · Sponsor: NOVARTIS

Drug application

FDA Application #

NDA018885

Application type

New Drug Application

Brand name

EMBOLEX

Generic name

Dihydroergotamine Mesylate

Active ingredients

DIHYDROERGOTAMINE MESYLATE; HEPARIN SODIUM; LIDOCAINE HYDROCHLORIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

NOVARTIS

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown